US Needs Drug Tracking System To Stop Counterfeits: Report

Law360, New York (February 13, 2013, 5:36 PM EST) -- Congress should authorize and fund the U.S. Food and Drug Administration to create a nationwide drug tracking system in order to help crack down on potentially dangerous counterfeit drugs, according to an Institute of Medicine report released Wednesday.

The IOM report was released just one week after the FDA warned health care providers that it had discovered counterfeit batches of the cancer treatment Avastin were being sold by a New York distributor. Until a mandatory track-and-trace system is established, the FDA should work with the drug...
To view the full article, register now.